Menu
1-702-720-6310 info@microcapspecualtors.com

Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031

[at noodls] – 75d433fe-13d2-46d9-b0b5-63d3ec0e1c3d.pdf July 7, 2016 Eleven entitled to receive $22.5 million milestone payment for IND effectiveness CAMBRIDGE, Mass.–(BUSINESS WIRE)– Eleven Biotherapeutics, Inc. (NASDAQ: …
Source: New feed

Search